PRESS RELEASE published on 06/14/2024 at 14:52, 1 year 7 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research increases Cardiol Therapeutics Inc's price target to USD8.50 in Buy recommendation after positive results from phase II trial of CardiolRx for recurrent pericarditis treatment Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Phase II Trial CardiolRx
PRESS RELEASE published on 02/27/2024 at 14:16, 1 year 11 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024 FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRIEF published on 02/27/2024 at 14:16, 1 year 11 months ago Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRIEF published on 02/27/2024 at 14:16, 1 year 11 months ago Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
PRESS RELEASE published on 01/19/2024 at 12:41, 2 years ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided. Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE published on 08/30/2023 at 15:06, 2 years 5 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 05/24/2023 at 13:01, 2 years 8 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 04/11/2023 at 15:26, 2 years 9 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
Published on 02/04/2026 at 16:15, 5 hours 6 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 5 hours 36 minutes ago Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 6 hours 21 minutes ago Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 20:54, 27 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 45 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 1 hour 20 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 2 hours 26 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 2 hours 40 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 3 hours 17 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 3 hours 17 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 3 hours 36 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 3 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL